These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8820649)

  • 1. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection.
    Chabalgoity JA; Khan CM; Nash AA; Hormaeche CE
    Mol Microbiol; 1996 Feb; 19(4):791-801. PubMed ID: 8820649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella.
    Khan CM; Villarreal-Ramos B; Pierce RJ; Demarco de Hormaeche R; McNeill H; Ali T; Chatfield S; Capron A; Dougan G; Hormaeche CE
    J Immunol; 1994 Dec; 153(12):5634-42. PubMed ID: 7527446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase.
    Lee JJ; Sinha KA; Harrison JA; de Hormaeche RD; Riveau G; Pierce RJ; Capron A; Wilson RA; Khan CM
    Infect Immun; 2000 May; 68(5):2503-12. PubMed ID: 10768937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of abilities of Salmonella enterica serovar typhimurium aroA aroD and aroA htrA mutants to act as live vectors.
    Roberts M; Chatfield S; Pickard D; Li J; Bacon A
    Infect Immun; 2000 Oct; 68(10):6041-3. PubMed ID: 10992518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.
    Roberts M; Li J; Bacon A; Chatfield S
    Infect Immun; 1998 Jul; 66(7):3080-7. PubMed ID: 9632569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella.
    Khan CM; Villarreal-Ramos B; Pierce RJ; Riveau G; Demarco de Hormaeche R; McNeill H; Ali T; Fairweather N; Chatfield S; Capron A
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11261-5. PubMed ID: 7972044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.
    Chabalgoity JA; Villareal-Ramos B; Khan CM; Chatfield SN; de Hormaeche RD; Hormaeche CE
    Infect Immun; 1995 Jul; 63(7):2564-9. PubMed ID: 7790070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
    Karem KL; Bowen J; Kuklin N; Rouse BT
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.
    Ward SJ; Douce G; Figueiredo D; Dougan G; Wren BW
    Infect Immun; 1999 May; 67(5):2145-52. PubMed ID: 10225867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA.
    Orr N; Galen JE; Levine MM
    Vaccine; 2001 Feb; 19(13-14):1694-700. PubMed ID: 11166893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultry.
    Buckley AM; Wang J; Hudson DL; Grant AJ; Jones MA; Maskell DJ; Stevens MP
    Vaccine; 2010 Jan; 28(4):1094-105. PubMed ID: 19853682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium.
    Dunstan SJ; Simmons CP; Strugnell RA
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):111-9. PubMed ID: 12832114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment.
    Foynes S; Holley JL; Garmory HS; Titball RW; Fairweather NF
    Vaccine; 2003 Mar; 21(11-12):1052-9. PubMed ID: 12559779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice.
    Sinha K; Mastroeni P; Harrison J; de Hormaeche RD; Hormaeche CE
    Infect Immun; 1997 Apr; 65(4):1566-9. PubMed ID: 9119506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.
    Roberts M; Bacon A; Li J; Chatfield S
    Infect Immun; 1999 Aug; 67(8):3810-5. PubMed ID: 10417142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.
    Somner EA; Ogun SA; Sinha KA; Spencer Valero LM; Lee JJ; Harrison JA; Holder AA; Hormaeche CE; Khan ACM
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():221-229. PubMed ID: 10206702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines.
    Abd El Ghany M; Jansen A; Clare S; Hall L; Pickard D; Kingsley RA; Dougan G
    Infect Immun; 2007 Apr; 75(4):1835-42. PubMed ID: 17296764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
    Barry EM; Gomez-Duarte O; Chatfield S; Rappuoli R; Pizza M; Losonsky G; Galen J; Levine MM
    Infect Immun; 1996 Oct; 64(10):4172-81. PubMed ID: 8926085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.